PANTOLOC

This brand name is authorized in Austria, Canada, Estonia, Hong Kong SAR China, Lithuania, Poland, South Africa, UK.

Active ingredients

The drug PANTOLOC contains one active pharmaceutical ingredient (API):

1	Pantoprazole UNII 6871619Q5X - PANTOPRAZOLE SODIUM
	Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells.
	Read more about Pantoprazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PANTOLOC CONTROL Gastro-resistant tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC02	Pantoprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02229453, 02241804
EE	Ravimiamet	1422593, 1422605
HK	Department of Health Drug Office	42486, 44676, 45019, 65789
LT	Valstybinė vaistų kontrolės tarnyba	1050565, 1050566, 1050567, 1050568
PL	Rejestru Produktów Leczniczych	100206490
ZA	Health Products Regulatory Authority	28/11.4.3/0407, 33/11.4.3/0041, 34/11.4.3/0005